Coronavirus Vaccine Research

US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine Boosters
US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine BoostersIANSJun 3, 2021 12:45 PM +05:30 IST
Road To Atmanirbhar Bharat: Dr. Harsh Vardhan On India As A Healthcare Hub 
Road To Atmanirbhar Bharat: Dr. Harsh Vardhan On India As A Healthcare Hub Swarajya VideosJan 22, 2021 02:44 PM +05:30 IST
Australia Abandons Efforts To Develop Homegrown Covid-19 Vaccine After Volunteers In Trials Develop Antibodies For HIV
Australia Abandons Efforts To Develop Homegrown Covid-19 Vaccine After Volunteers In Trials Develop Antibodies For HIVSwarajya StaffDec 14, 2020 09:57 AM +05:30 IST
Chennai Volunteer Claims Neurological Complications From Covid Test Vaccine, Serum Institute Says Symptoms Not Related To Vaccine Trials
Chennai Volunteer Claims Neurological Complications From Covid Test Vaccine, Serum Institute Says Symptoms Not Related To Vaccine Trials Swarajya StaffDec 1, 2020 04:54 PM +05:30 IST
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSK
UK’s Chief Scientific Adviser Patrick Vallance Faces Questions About Conflict Of Interest For Holding Shares in Pharma Giant GSKSwarajya StaffSep 25, 2020 07:22 PM +05:30 IST
Govt Plans To Issue E-Certificates To Vaccinated Individuals Once An Effective Vaccine Is Developed
Govt Plans To Issue E-Certificates To Vaccinated Individuals Once An Effective Vaccine Is DevelopedSwarajya StaffSep 19, 2020 01:05 PM +05:30 IST
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 Participants
Pfizer And BioNTech Announce Plan To Expand Phase 3 Covid-19 Vaccine Trial By 50% To 44000 ParticipantsSwarajya StaffSep 13, 2020 05:17 PM +05:30 IST
Safe So Far: Bharat Biotech - ICMR's Covaxin Shows No Adverse Effects In Preliminary Phase I Results
Safe So Far: Bharat Biotech - ICMR's Covaxin Shows No Adverse Effects In Preliminary Phase I ResultsSwarajya StaffAug 14, 2020 08:50 AM +05:30 IST
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  
President Trump Announces A $1.5 billion Deal with Moderna For 100 Million Doses of Coronavirus Vaccine  Swarajya StaffAug 12, 2020 12:07 PM +05:30 IST
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be Dosed
US Government Backed Moderna’s Coronavirus Vaccine Begins Phase 3 Final-Stage Testing, 30000 People To Be DosedSwarajya StaffJul 27, 2020 08:19 PM +05:30 IST
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. GovernmentSwarajya StaffJul 22, 2020 05:55 PM +05:30 IST
Serum Institute To Start Human Trials For Oxford Vaccine In India From August 
Serum Institute To Start Human Trials For Oxford Vaccine In India From August Swarajya StaffJul 21, 2020 10:06 AM +05:30 IST
‘Positive News’ On Oxford Coronavirus Vaccine, Now Undergoing Phase III Human Trials, Likely To Come As Early As Today
‘Positive News’ On Oxford Coronavirus Vaccine, Now Undergoing Phase III Human Trials, Likely To Come As Early As TodaySwarajya StaffJul 16, 2020 01:32 PM +05:30 IST
Moderna Coronavirus Vaccine Induced Desired Immune Response In All 45 People Evaluated, Phase-3 Clinical Trial Soon
Moderna Coronavirus Vaccine Induced Desired Immune Response In All 45 People Evaluated, Phase-3 Clinical Trial SoonSwarajya StaffJul 15, 2020 01:23 PM +05:30 IST
COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next Week
COVAXIN: India’s First Indigenous COVID-19 Vaccine Candidate To Begin Human Trials Next WeekSwarajya StaffJul 7, 2020 05:57 PM +05:30 IST
US Green Signals Four Candidate COVID-19 Vaccines For Clinical Trials; Six More Under Review
US Green Signals Four Candidate COVID-19 Vaccines For Clinical Trials; Six More Under ReviewSwarajya StaffJul 1, 2020 11:14 AM +05:30 IST
First Volunteer Who Receives Imperial College’s RNA-based COVID-19 Vaccine In Good Health, Trials Enters Next Phase
First Volunteer Who Receives Imperial College’s RNA-based COVID-19 Vaccine In Good Health, Trials Enters Next PhaseSwarajya StaffJun 24, 2020 12:22 PM +05:30 IST
Here Is A List Of Seven Organisations In The Race To Develop A Coronavirus Vaccine 
Here Is A List Of Seven Organisations In The Race To Develop A Coronavirus Vaccine Swarajya StaffMay 19, 2020 05:45 PM +05:30 IST
Coronavirus Vaccine Developed By US Biotech Firm Moderna Produces COVID-19 Antibodies in All 45 Participants  
Coronavirus Vaccine Developed By US Biotech Firm Moderna Produces COVID-19 Antibodies in All 45 Participants  Swarajya StaffMay 19, 2020 11:33 AM +05:30 IST
Glenmark Pharma Begins Phase 3 Of Clinical Trials For Favipiravir, Potential COVID-19 Drug In India
Glenmark Pharma Begins Phase 3 Of Clinical Trials For Favipiravir, Potential COVID-19 Drug In IndiaSwarajya StaffMay 12, 2020 01:36 PM +05:30 IST
Load More